Weekly FDA Drug Pipeline Calendar (Dec 5 - Dec 9)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
The American Society of Hematology (ASH) Annual Meeting is set to begin this week. This conference, which carries from December 10 to the 13th, is an excellent opportunity for companies to present new or updated data from ongoing trials. This week's watchlist includes presentations scheduled for the conference, as well as data released in abstracts.
$Pfizer (PFE.US)$ and $BioNTech (BNTX.US)$ said Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years.
Chinese authorities eased Covid testing requirements across major cities over the weekend.
$Kintara Therapeutics (KTRA.US)$: The FDA granted Fast Track Designation (FTD) to REM-001 therapy to treat cutaneous metastatic breast cancer (CMBC).
$Aeglea BioTherapeutics (AGLE.US)$: delayed the release of interim clinical data from the ongoing Phase 1/2 clinical trial of pegtarviliase in Classical Homocystinuria.
$CNS Pharmaceuticals (CNSP.US)$ filed an amendment to an S-1 filing from October regarding an offering.
EVENTS TO WATCH
Thursday, December 8
European Society for Medical Oncology Immuno-Oncology Congress(ESMO IO) December 8-10
European Society for Medical Oncology Immuno-Oncology Congress(ESMO IO) December 8-10
Saturday, December 10
American Society of Hematology Annual Meeting (ASH) December 10-13
American Society of Hematology Annual Meeting (ASH) December 10-13
Source: CNBC, BioPharmCatalyst, Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
913Followers
8Following
1481Visitors
Follow